A CD8 T effector gene signature including CD8A, CD8B, EOMES, GZMA, GZMB, IFNG, and PRF1 was established to identify activated T cells and can be used to evaluate the abundance of CTLs in the tumor microenvironment [15]. The gene discussed is CD8A; the disease is neoplasm.